Kintor Pharmaceutical Ltd
Kintor Pharmaceutical's GHG Emissions Data Preview
In 2023, Kintor Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Kintor Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Verified Sources Behind Kintor Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kintor Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Kintor Pharmaceutical's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Kintor Pharmaceutical amounted to 3,719.63 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Kintor Pharmaceutical decreased by 8.83%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Kintor Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Kintor Pharmaceutical's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Kintor Pharmaceutical were 5.71 metric tons of CO₂ equivalent (tCO₂e). a
Has Kintor Pharmaceutical reduced its Scope 1 emissions over time?
Since 2021, Kintor Pharmaceutical's Scope 1 emissions have decreased by 80.13%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Kintor Pharmaceutical's Scope 1 emissions decreased by 13.88%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Kintor Pharmaceutical's Scope 2 emissions?
In 2023, Kintor Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 3,713.92 tCO₂e without specifying the calculation method. a
Has Kintor Pharmaceutical reduced its Scope 2 emissions over time?
Since 2021, Kintor Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Kintor Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2022), Kintor Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Kintor Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Kintor Pharmaceutical use for Scope 2 reporting?
In 2023, Kintor Pharmaceutical reported its Scope 2 emissions using an unspecified methodology. a
Kintor Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Kintor Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers
In 2021, Kintor Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 28.73 tCO₂e and total revenues of USD 5 millions. This translates into an emissions intensity of 5.35 tCO₂e per millions USD. b
Kintor Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers
How does Kintor Pharmaceutical's GHG emissions intensity compare to its peers?
In 2021, Kintor Pharmaceutical reported a Scope 1 emissions intensity of 5.35 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. b
Where does Kintor Pharmaceutical rank on GHG emissions intensity within its industry?
In 2021, Kintor Pharmaceutical ranked 9 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). b
Kintor Pharmaceutical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. b